Larvol Delta - A-phase-I-trial-of-CT900-a-novel-folate-receptormediated-thymidylate-synthase-inhibitor-with-expansion-cohorts-in-patients-with-high-grade-serous-ovarian-cancer

idetrexed (CT900) - Carrick Therap

dexamethasone - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/35984704

Aug 21, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next